Session » Epidemiology & Public Health Poster I

Date: Saturday, November 16, 2024

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2024

10:30AM-12:30PM: Abstract Number: 0174

A Nationwide Analysis of Gender and Racial Disparities in Patients with Systemic Sclerosis and Acute Coronary Syndrome

10:30AM-12:30PM: Abstract Number: 0139

Analysis of Rheumatoid Arthritis Epidemiology in Mexico Using the GBD 2019 Study and Forecasting Future Trends for 2030 and 2040

10:30AM-12:30PM: Abstract Number: 0170

Association of General Physical Functioning, Valued Life Activity (VLA) Disability, and Use of Accommodations with Depressive Symptoms Among Individuals with Systemic Lupus Erythematosus (SLE)

10:30AM-12:30PM: Abstract Number: 0171

Associations Between Discrimination Experiences and Patient-Reported Outcomes Among Asian Individuals with Systemic Lupus Erythematosus (SLE)

10:30AM-12:30PM: Abstract Number: 0143

Behavioral Factors and Chronic Conditions Associated with Rheumatoid Arthritis, KNHANES 2010 to 2021

10:30AM-12:30PM: Abstract Number: 0149

Beliefs on Self-Management in Rheumatoid Arthritis Compared to Other Chronic Diseases Using the Nationally Representative Medical Expenditure Panel Survey

10:30AM-12:30PM: Abstract Number: 0154

Chronic Sinusitis Predicting Interstitial Lung Disease in Sjögren’s Syndrome: A Comprehensive USA Population Study (2004-2024)

10:30AM-12:30PM: Abstract Number: 0147

Clinical Characteristics and Biomarkers Associated with Detectable High-Sensitivity Cardiac Troponin in Patients with Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 0145

Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 0155

Comparative Analysis and Outcomes of COVID 19: Unveiling Trends in Rheumatological vs. Non-Rheumatological Disease Patients

10:30AM-12:30PM: Abstract Number: 0161

Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022

10:30AM-12:30PM: Abstract Number: 0136

Demographic and Clinical Characteristics of Patients with SLE Across 5 Registries – the LupusNet Federated Data Network

10:30AM-12:30PM: Abstract Number: 0130

Depression Genetic Risk, Diagnoses, and Treatments in Association with Cardiovascular Disease Events Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis in the All of Us Research Program

10:30AM-12:30PM: Abstract Number: 0175

Do Knee Strength and Pain Relate to Developing Stair Climbing Difficulty for Knee Osteoarthritis?

10:30AM-12:30PM: Abstract Number: 0172

Effectiveness of mRNA COVID-19 Vaccines in Patients with Rheumatologic Conditions on Immunosuppressive Therapies

10:30AM-12:30PM: Abstract Number: 0146

Enhancing Pre-Biologic Response Modifier Screening for Coccidioidomycosis in Endemic Regions

10:30AM-12:30PM: Abstract Number: 0167

Epidemiology of Falls in a Diverse Cohort of Adults with SLE

10:30AM-12:30PM: Abstract Number: 0140

Estimation of 10-year Cardiovascular (CV) Risk and Traditional CV Risk Factors Distribution in Patients with Rheumatoid Arthritis from Three Italian Macro-areas

10:30AM-12:30PM: Abstract Number: 0165

Exploring Changes in Daily Behaviors with Changes in Physical Function over 24 Weeks in Adults with Knee OA

10:30AM-12:30PM: Abstract Number: 0153

Frequencies and Rates of All-Cause Emergency Visits and Hospitalizations in Persons with Inflammatory Arthritis Conditions and Gout: A Systematic Review

10:30AM-12:30PM: Abstract Number: 0152

Hydroxychloroquine and Chloroquine Retinopathy in Hispanic Patients with Rheumatic Diseases

10:30AM-12:30PM: Abstract Number: 0151

Immunoproteomic Profiling of Antibodies in Autoimmune Diseases

10:30AM-12:30PM: Abstract Number: 0169

Impact of Sense of Control Among People Living with SLE

10:30AM-12:30PM: Abstract Number: 0157

Knowledge and Attitudes About Delta-9-tetrahydrocannabinol (THC) Impact Real-world Practice in an International Group of Rheumatologists

10:30AM-12:30PM: Abstract Number: 0166

Limitations in Activities of Daily Living Among Individuals with SLE

10:30AM-12:30PM: Abstract Number: 0131

Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies After SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study

10:30AM-12:30PM: Abstract Number: 0163

Modification of 2017 EULAR/ACR Myositis Classification Criteria for Dermatomyositis, Clinically Amyopathic Dermatomyositis, and Immune-mediated Necrotizing Myopathy

10:30AM-12:30PM: Abstract Number: 0144

More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups

10:30AM-12:30PM: Abstract Number: 0132

Patients with Systemic Autoimmune Rheumatic Diseases Remain at Risk for Hospitalization for COVID-19 Infection in the Omicron Era (2022-2024): A Retrospective Cohort Study

10:30AM-12:30PM: Abstract Number: 0159

Prevalence and Potential Factors Associated with Polypharmacy in Individuals with Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 0156

Psoriasis and Psoriatic Arthritis Are Independent Risk Factors for Non-Fatal Cardiovascular Admissions in Transition-Age Young Adults

10:30AM-12:30PM: Abstract Number: 0176

Race-Based Differences in Immune Responses Following an Episode of Acute Low Back Pain Among Those Who Develop Chronic LBP and Those Who Do Not

10:30AM-12:30PM: Abstract Number: 0168

Real-world Glucocorticoid Prescription Patterns in Patients with Lupus Nephritis: A Retrospective Study Using a Healthcare Insurance Claims Database

10:30AM-12:30PM: Abstract Number: 0135

Rheumatoid Arthritis Associated Risk of Venous Thromboembolism Is Not Dependent on Disease Duration: United Kingdom Based Population Study

10:30AM-12:30PM: Abstract Number: 0158

Rheumatoid Arthritis Testing Patterns by Physicians and Advanced Practice Providers from a National Commercial Laboratory, 2014 – 2023

10:30AM-12:30PM: Abstract Number: 0138

SARS-CoV-2 Vaccine Acceptance, Hesitancy and Uptake in a Cohort of Patients with Inflammatory Rheumatic Diseases (IRD)

10:30AM-12:30PM: Abstract Number: 0164

Sleep Quality Is Associated with Perceived Memory Performance in Females with Osteoarthritis: A Population-based Cross-sectional Study

10:30AM-12:30PM: Abstract Number: 0162

Statewide Burden of Low Back Pain in the United States and Its Trend from 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2022

10:30AM-12:30PM: Abstract Number: 0160

Supplement Use in a Diverse Cohort of Individuals with SLE

10:30AM-12:30PM: Abstract Number: 0173

Systemic Lupus Erythematosus Mortality—United States, 2018–2022

10:30AM-12:30PM: Abstract Number: 0133

The Association Between Gout and Gallstone Disease: US General Population Analysis

10:30AM-12:30PM: Abstract Number: 0150

The Characteristics of a Northern Israeli Cohort of Patients with Behcet’s Syndrome

10:30AM-12:30PM: Abstract Number: 0141

The Effect of Systemic Immunosuppressive Therapies on Cardiovascular Risk in Psoriatic Arthritis Patients

10:30AM-12:30PM: Abstract Number: 0142

The Impact of Hospital Region on Mortality and Other Outcomes in Patients with Gout: A Two-Year Nationwide Analysis

10:30AM-12:30PM: Abstract Number: 0148

The Incidence and Prevalence of Sarcoidosis in England

10:30AM-12:30PM: Abstract Number: 0137

The Problem of Pain in Rheumatology: Sociodemographic and Disease-related Correlates of Agreement Between Structured Data Elements and Clinical Notes in Chronic Pain Documentation Practices in EHR

10:30AM-12:30PM: Abstract Number: 0134

Use of Oral Contraceptives in Females with Rheumatoid Arthritis Is Not Associated with an Increased Risk of Venous Thromboembolism: United Kingdom-population Based Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].